United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Immunology
Rank in SubField 1: 263 out of 61,090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74,977 | 84,792 |
| Total Cites | 639 | 668 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 258 | 263 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 310 | 316 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 605 | 625 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.07 |
| Self-Citation Percentage |
4.34%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 569 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147,086 | 154,013 |
| Total Cites | 602 | 624 |
| H-index | 10 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 167 | 173 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 193 | 201 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 576 | 589 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
3.53%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 740 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 185,021 | 214,731 |
| Total Cites | 514 | 531 |
| H-index | 6 | 6 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 186 | 186 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 203 | 203 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 482 | 496 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
3.20%
|
|
Vesely, Matthew D.
Yale School of Medicine,
2021 Rank: 217,420
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 872 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 217,420 | 248,866 |
| Total Cites | 765 | 792 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 270 | 273 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 289 | 292 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 713 | 733 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
3.41%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.